• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Depression, Anxiety, and Quality of Life in Hepatitis C Patients Treated with Direct-Acting Antiviral Agents.接受直接抗病毒药物治疗的丙型肝炎患者的抑郁、焦虑和生活质量
Turk J Gastroenterol. 2022 May;33(5):449-450. doi: 10.5152/tjg.2020.19968.
2
[Effectiveness and safety of direct-acting antiviral agents for treatment of patients with chronic hepatitis C virus infection].直接作用抗病毒药物治疗慢性丙型肝炎病毒感染患者的有效性和安全性
Zhonghua Gan Zang Bing Za Zhi. 2018 Mar 20;26(3):175-178. doi: 10.3760/cma.j.issn.1007-3418.2018.03.004.
3
[A case report about curing chronic hepatitis C in children by direct-acting antiviral drugs].[关于直接作用抗病毒药物治愈儿童慢性丙型肝炎的病例报告]
Zhonghua Gan Zang Bing Za Zhi. 2021 Dec 20;29(12):1196-1197. doi: 10.3760/cma.j.cn501113-20200814-00455.
4
Management of dialysis patients with hepatitis C virus in the era of direct-acting antiviral therapy.直接抗病毒治疗时代丙型肝炎病毒透析患者的管理
Ther Apher Dial. 2024 Feb;28(1):158-159. doi: 10.1111/1744-9987.14060. Epub 2023 Sep 4.
5
Direct-acting antiviral treatments in Australia for children with chronic hepatitis C virus infection.
Med J Aust. 2023 Mar 20;218(5):229-230. doi: 10.5694/mja2.51852. Epub 2023 Feb 16.
6
Authors response to Management of dialysis patients with hepatitis C virus in the era of direct-acting antiviral therapy.作者对直接抗病毒治疗时代丙型肝炎病毒透析患者管理的回应。
Ther Apher Dial. 2024 Feb;28(1):160-161. doi: 10.1111/1744-9987.14070. Epub 2023 Sep 28.
7
Creating an environment for equitable access to direct-acting antiviral therapy for people who inject drugs with hepatitis C.为注射毒品感染丙型肝炎的人创造公平获得直接抗病毒治疗的环境。
Liver Int. 2020 Oct;40(10):2353-2355. doi: 10.1111/liv.14661.
8
Behind the Decrease of Liver Stiffness After Successful Hepatitis C Virus Eradication with Direct-Acting Antiviral Agents.直接抗病毒药物成功清除丙型肝炎病毒后肝脏硬度降低的背后原因。
Turk J Gastroenterol. 2022 Feb;33(2):169-170. doi: 10.5152/tjg.2021.20736.
9
Outcomes of accidental pregnancy during chronic hepatitis C treatment with direct-acting antiviral agents.使用直接抗病毒药物治疗慢性丙型肝炎期间意外怀孕的结局
Liver Int. 2023 Sep;43(9):2044-2045. doi: 10.1111/liv.15672. Epub 2023 Jul 20.
10
[Selection of direct-acting antiviral agents for chronic hepatitis C infection].[慢性丙型肝炎感染直接抗病毒药物的选择]
Zhonghua Gan Zang Bing Za Zhi. 2018 Mar 20;26(3):169-172. doi: 10.3760/cma.j.issn.1007-3418.2018.03.002.

本文引用的文献

1
Evaluation of depression, anxiety and quality of life in hepatitis C patients who treated with direct acting antiviral agents.接受直接抗病毒药物治疗的丙型肝炎患者的抑郁、焦虑及生活质量评估
Turk J Gastroenterol. 2019 Sep;30(9):801-806. doi: 10.5152/tjg.2019.18679.
2
EASL Recommendations on Treatment of Hepatitis C 2018.2018年欧洲肝脏研究学会丙型肝炎治疗推荐意见
J Hepatol. 2018 Aug;69(2):461-511. doi: 10.1016/j.jhep.2018.03.026. Epub 2018 Apr 9.
3
Adverse effects of direct acting antiviral-based regimens in chronic hepatitis C patients: a Brazilian experience.基于直接作用抗病毒药物的治疗方案在慢性丙型肝炎患者中的不良反应：巴西的经验。
Int J Clin Pharm. 2017 Dec;39(6):1304-1311. doi: 10.1007/s11096-017-0552-1. Epub 2017 Oct 27.
4
Biostatistics Series Module 10: Brief Overview of Multivariate Methods.生物统计学系列模块10：多元方法概述
Indian J Dermatol. 2017 Jul-Aug;62(4):358-366. doi: 10.4103/ijd.IJD_296_17.
5
Simultaneous and selective inference: Current successes and future challenges.同步与选择性推断：当前的成功与未来的挑战。
Biom J. 2010 Dec;52(6):708-21. doi: 10.1002/bimj.200900299. Epub 2010 Nov 19.

Depression, Anxiety, and Quality of Life in Hepatitis C Patients Treated with Direct-Acting Antiviral Agents.

作者信息

Khoshnam-Rad Niloofar, Kohneloo Aarefeh Jafarzadeh, Kargar Mona

机构信息

Department of Clinical Pharmacy, Tehran University of Medical Sciences School of Pharmacy, Tehran, Iran.

Department of Epidemiology and Biostatistics, Tehran University of Medical Sciences School of Public Health, Tehran, Iran; Research Center for Rational Use of Drugs, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

Turk J Gastroenterol. 2022 May;33(5):449-450. doi: 10.5152/tjg.2020.19968.

DOI:10.5152/tjg.2020.19968
PMID:35678804
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11160423/
Abstract
摘要